Key highlights of the past week include regulatory and pipeline updates, acquisition deals, and more.

NEW YORK, Sept. 23, 2019 -- The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on.

Bob Azelby is replaced by Randy Hassler, who according to his LinkedIn profile was the senior vice president of pharmaceutical operations at Alder for nearly five and a half years.

H. Lundbeck A/S (Lundbeck) and Alder BioPharmaceuticals (ALDR) (Alder) each filed updated tender offer materials with the U.S. Securities and Exchange Commission (SEC) in connection with Lundbeck's pending tender offer (the Offer), for all outstanding shares of Alder, whereby Alder stockholders are being offered an upfront payment for USD 18.00 per share in cash, along with one non-tradeable Contingent Value Right (CVR) that entitles them to an additional USD 2.00 per share upon approval of eptinezumab by the European Medicines Agency, representing a total potential consideration of USD 20.00 per share. The Offer commenced on 23 September 2019, and on the same day Lundbeck filed an offer to purchase and related letter of transmittal setting forth the terms of the Offer with the SEC and began mailing such materials to Alder stockholders.

Q2 2019 Alder Biopharmaceuticals Inc Earnings Call

Alder BioPharmaceuticals, Inc. (ALDR), a biopharmaceutical company focused on developing therapeutic antibodies for the treatment of migraine, today announced dosing of the first patient in a Phase 1 clinical study to evaluate ALD1910 as a preventive treatment for migraine. ALD1910 is an investigational monoclonal antibody (mAb) that inhibits pituitary adenylate cyclase-activating polypeptide (PACAP), an important signaling molecule in the pathophysiology of migraine.

BALA CYNWYD, PA / ACCESSWIRE / September 17, 2019 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Alder BioPharmaceuticals, Inc. ...

This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. Yuma Energy (AMEX: YUMA) shares were up 5.1% ...

WILMINGTON, Del., Sept. 19, 2019 -- Rigrodsky & Long, P.A. announces that it is investigating: Alder BioPharmaceuticals, Inc. (NASDAQ GM: ALDR) regarding possible breaches.

Seattle's biotech community has a reputation for developing companies that are eventually acquired and that has restricted its growth. But a few companies are well-positioned to change that narrative.

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of June. At Insider Monkey, we follow nearly 750 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are […]

NEW YORK, NY / ACCESSWIRE / September 20, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in ...

The investigation concerns whether United Community and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of United Community to First Defiance Financial Corp. Under the terms of the agreement, United Community shareholders will receive 0.3715 shares of First Defiance common stock for each share of United Community common stock. If you are a United Community shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/united-community-financial-corp-ucfc-first-defiance-merger-stock/.

NEW YORK, Sept. 27, 2019 -- The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on.

The investigation concerns whether Pivotal Software and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Pivotal Software to VMware, Inc. If you are a Pivotal Software shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/pivotal-software-inc-merger-stock-vmware.

DAFNA Capital Management was founded in 1999 by Dr. Nathan Fischel, who is the fund’s CEO. Dr. Fischel is Pediatric Hematologist-Oncologist with a long career in medicine. He graduated from Technion School of Medicine in Israel and completed his residency at the Children’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston. He continued his […]

NEW YORK , Sept. 17, 2019 /PRNewswire/ --  WeissLaw LLP  is investigating possible breaches of fiduciary duty and other violations of law by the Board of Alder Biopharmaceuticals, Inc. ("Alder" ...

Alder BioPharmaceuticals (ALDR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).

Cross the age-old barrier of low P/E investing. bet on these five stocks that boast rising P/E.

Zacks.com featured highlights include: Columbia Sportswear, American Woodmark, DICK'S Sporting, Alder and Leap